Insight

Pricing for survival

As demand for pharmaceutical cost containment intensifies, novel drug-pricing approaches are critical

Specialty drug costs are so high that the entire pharmaceutical industry is now under scrutiny for its pricing practices.  Although payers and regulators see the need for innovation, there is a much higher onus on drug companies seeking market access to demonstrate the value of their products.  In this piece, we explore the practical approaches to pricing for value that pharma manufacturers can leverage today.

Pricing for Survival:

As demand for pharmaceutical cost containment intensifies, novel drug-pricing approaches are critical

Related content


KPMG Healthcare & Life Sciences Institute

Register to receive timely insights